List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 128 studies with search of: diabetic foot ulcers
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting The ASCEND Study: A Study to Investigate the Safety and Clinical Effect of Nexagon to Treat Slow Healing Diabetic Foot Ulcers
Condition: Diabetic Foot Ulcer
Interventions: Drug: Nexagon®;   Drug: Nexagon® vehicle
Sponsor: CoDa Therapeutics Inc.
Gender: Both
Phases: Phase I / Phase II
Other IDs: NEX-ULC-003
Start Date: April 2009
2 Recruiting Evaluation of the Effect of Vivostat Platelet Rich Fibrin(PRF) in the Treatment of Diabetic Foot Ulcers
Condition: Diabetic Foot Ulcers
Intervention: Device: Vivostat PRF
Sponsor: Vivostat
Gender: Both
Phase: Phase IV
Other IDs: 2007-001
Start Date: July 2008
3 Terminated Efficacy and Safety Study in the Treatment of Chronic Diabetic Foot Ulcers
Condition: Diabetic Foot Ulcer
Intervention: Device: Dermal - Living Skin Replacement (Dermal - LSR)
Sponsor: ApoPharma
Gender: Both
Phase: Phase III
Other IDs: RS03-2004
Start Date: February 2006
4 Completed A Prospective Study of Endothelial Dysfunction and Diabetic Foot Ulcer Risk
Condition: Diabetic Foot Ulcers
Intervention: Device: Prevention Diabetic Foot Ulcer
Sponsor: Department of Veterans Affairs
Gender: Both
Phase: Phase II
Other IDs: A2016R
Start Date: October 1999
5 Recruiting Monochromatic Phototherapy on Diabetic Foot Ulcers
Condition: Diabetic Foot Ulcers
Interventions: Device: Monochromatic phototherapy, Biolight®;   Device: Monochromatic phototherapy
Sponsor: Biolight AB
Gender: Both
Phase: Phase III
Other IDs: BL-039,   H15:321/2008
Start Date: August 2008
6 Recruiting Matrix Metalloproteinase-1/Tissue Inhibitor of Metalloproteinase-1 (MMP-1/TIMP-1) Ratio and Diabetic Foot Ulcers
Condition: Diabetic Foot Ulcer
Intervention: Other: Picture + MMPs and TIMP1 at week 0 and week 4
Sponsor: University Hospital, Grenoble
Gender: Both
Phase: Phase 0
Other IDs: 2008-A00155-50
Start Date: May 2009
7 Terminated BST-DERMON Versus Standard of Care in the Treatment of Diabetic Foot Ulcers
Condition: Diabetic Foot Ulcer
Intervention: Device: BST-DermOn
Sponsor: BioSyntech Canada Inc.
Gender: Both
Phase: Phase III
Other IDs: DO-CIP01-P
Start Date: February 2007
8 Recruiting A Dose Finding Study of Topically Applied I-020201 as an Adjunct to Good Standard-of-care in Patients With Chronic Diabetic Foot Ulcers
Condition: Diabetic Foot Ulcer
Interventions: Procedure: Good Standard of Care (GSoC);   Biological: Vehicle;   Biological: I-020201
Sponsor: Kuros Biosurgery AG
Gender: Both
Phase: Phase II
Other IDs: CS I-020201/01
Start Date: May 2009
9 Completed Randomized, Controlled Multicenter Trial of Vacuum Assisted Closure Therapy™ in Diabetic Foot Ulcers
Condition: Diabetic Foot Ulcers
Intervention: Device: V.A.C. ® System
Sponsor: KCI USA, Inc.
Gender: Both
Phase: Phase IV
Other IDs: VAC2001-08
Start Date: May 2002
10 Recruiting Trial of Herb Yuyang Ointment to Diabetic Foot Ulcer
Condition: Diabetic Foot Ulcer
Intervention: Drug: herb ointment
Sponsors: Guiyang No.1 People's Hospital;   Beijing University of Chinese Medicine;   Third Military Medical University
Gender: Both
Phase: Phase II
Other IDs: SFL-2008-11,   ISRCTN20081114,   NCI-197-4128D,   R01-020225-1
Start Date: November 2008
11 Completed Hyperspectral Imaging to Assess and Predict Diabetic Foot Ulcers
Condition: Diabetic Foot Ulcers
Intervention:
Sponsors: HyperMed, Inc;   The Cleveland Clinic;   Olive View-UCLA Medical Center;   University of Pennsylvania
Gender: Both
Phase:
Other IDs: 2005-001,   R42-DK069871
Start Date: March 2006
12 Active, not recruiting TheraGauze™ Alone and Regranex®Gel 0.01% Plus TheraGauze™ in the Treatment of Wagner Stage I Diabetic Foot Ulcers
Condition: Diabetic Foot Ulcer
Interventions: Device: TheraGauze;   Drug: Regranex
Sponsor: Soluble Systems, LLC
Gender: Both
Phase:
Other IDs: SS-0601
Start Date: September 2006
13 Recruiting Clinical Evaluation of DCB-WH1 in Healing of Chronic Diabetic Foot Ulcers
Condition: Chronic Diabetic Foot Ulcers
Interventions: Drug: DCB-WH1 ointment;   Drug: Placebo
Sponsor: Oneness Biotech Co., Ltd.
Gender: Both
Phase: Phase II
Other IDs: DCB-WH1-CP001
Start Date: May 2008
14 Recruiting The Mechanism of Action of the Unite Biomatrix in Diabetic Foot Ulcer
Condition: Diabetic Foot Ulcers
Interventions: Device: Unite Biomatrix;   Other: Saline and Gauze
Sponsor: Synovis Surgical Innovations
Gender: Both
Phase:
Other IDs: U-0801
Start Date: January 2009
15 Recruiting Safety and Efficacy of HO/03/03 10μg in the Treatment of Plantar Neuropathic Diabetic Foot Ulcers
Condition: Diabetic Foot Ulcer
Interventions: Drug: HO/03/03 10µg;   Drug: Placebo
Sponsors: HealOr;   Clinigene International Ltd.;   Cato Research
Gender: Both
Phase: Phase II
Other IDs: HO-09-01
Start Date: February 2010
16 Recruiting Safety and Efficacy Study of an Interactive Wound Dressing (KC002) for the Treatment of Diabetic Foot Ulcers
Conditions: Foot Ulcer;   Diabetes
Interventions: Device: KC-002;   Other: Conventional Wound Therapy
Sponsor: KeraCure
Gender: Both
Phase: Phase II
Other IDs:
Start Date: January 2006
17 Not yet recruiting Bioburden Reduction of Diabetic Foot Ulcer
Condition: Diabetic Foot Ulcer
Intervention: Device: Noveon laser
Sponsor: Nomir Medical Technologies
Gender: Both
Phase: Phase I
Other IDs: 12.001a
Start Date: November 2008
18 Completed A Study Evaluating Topical Recombinant Human Vascular Endothelial Growth Factor (Telbermin) for Induction of Healing of Chronic, Diabetic Foot Ulcers
Condition: Foot Ulcer
Intervention: Drug: rhuMAb VEGF (telbermin)
Sponsor: Genentech
Gender: Both
Phase: Phase I
Other IDs: VGF2763g
Start Date:
19 Not yet recruiting Shockwave Treatment of Diabetic Foot Ulcer: Step I
Condition: Chronic Diabetic Foot Ulcers
Intervention: Procedure: Extracorporeal Shock Wave
Sponsor: Technische Universität München
Gender: Both
Phase:
Other IDs: 2456/09
Start Date: August 2009
20 Completed The Effects of Vacuum-Compression Therapy on the Healing of Diabetic Foot Ulcers
Condition: Diabetic Foot Ulcer
Intervention: Device: Vasotrain-447
Sponsor: Zahedan University of Medical Sciences
Gender: Both
Phase:
Other IDs: 86-456
Start Date: February 2006

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services